Loading page
Loading page
Loading substance route
Effects vary widely by individual, dose, and context.
The physical effects of 4-AcO-MET can be broken down into three components all of which progressively intensify proportional to dosage.
The cognitive effects of 4-AcO-MET are described by many as somewhat relaxing, yet fast-paced in style with similarities to psychedelics such as LSD or 2C-B which tend to be cognitively energetic and stimulating.
The visual geometry that is present throughout this trip can be described as somewhat similar in appearance to that of Psilocin, 4-AcO-DMT and 4-HO-MiPT but with far stronger synthetic digital undertones reminiscent of LSD or 2C-B. 4-AcO-MET can be comprehensively described through its variations as intricate in complexity, abstract in form, equally synthetic and organic in style, structured in organization, extremely brightly lit and multicoloured in scheme, glossy in shading, sharp in edges, large in size, fast in speed, smooth in motion, angular in corners, unimmersive in depth and consistent in intensity. The visuals have a contradictory 'natural' and 'synthetic' feel to them which is reminiscent of both LSD and Psilocybin. Higher dosages are significantly more likely to result in states of Level 8A visual geometry over Level 8B.
4-AcO-MET and its various other forms produce a full range of high level hallucinatory states in a fashion that is more consistent and reproducible than that of many other commonly used psychedelics.
The auditory effects of 4-AcO-MET are common in their occurrence and exhibit a full range of effects.
4-AcO-MET is not habit-forming and the desire to use it can actually decrease with repeated use. It is considered self-regulating by most users.
4-AcO-MET does not appear to produce physical dependence, with no documented withdrawal symptoms.
The exact toxic dose is unknown as no formal toxicity studies have been conducted on 4-AcO-MET. This compound has very limited history of human use.
Delusions are listed among possible cognitive effects during the acute experience. No specific data on psychosis incidence exists for this compound; standard psychedelic cautions apply regarding individuals with personal or family history of psychotic disorders.
No specific data on seizure risk exists for 4-AcO-MET.
4-AcO-MET, also known as metacetin, is a novel synthetic tryptamine that emerged primarily through the online research chemical market. As an acetate ester of 4-HO-MET and a structural homologue of 4-AcO-DMT, it represents one of many acetylated tryptamine derivatives that have been synthesized and…
Controlled under the Neue-psychoaktive-Stoffe-Gesetz (New Psychoactive Substances Act) as of July 18, 2019. Production, import with intent to market, administration to others, and trading are punishable offenses. Possession is illegal but not subject to criminal penalty. Ordering may potentially constitute incitement to place on the market.
Controlled as a Class A substance under the Misuse of Drugs Act 1971. Classification stems from being an ester of 4-HO-MET, which itself is controlled under the tryptamine catch-all clause.
Specifically named as a controlled substance under Verzeichnis E of Swiss narcotics legislation.
Not specifically scheduled under the Controlled Substances Act. However, as a structural analogue of psilocin (a Schedule I substance), sale for human consumption or use for illicit non-medical purposes could potentially be prosecuted under the Federal Analogue Act.
